Literature DB >> 21504242

Is there a role for pharmacoeconomics in developing countries?

Román Pérez Velasco, Yot Teerawattananon.   

Abstract

Mesh:

Year:  2011        PMID: 21504242     DOI: 10.2165/11591060-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  The public versus the World Health Organization on health system performance.

Authors:  R J Blendon; M Kim; J M Benson
Journal:  Health Aff (Millwood)       Date:  2001 May-Jun       Impact factor: 6.301

2.  A critique of the World Health Organisation's evaluation of health system performance.

Authors:  Jeff Richardson; John Wildman; Iain K Robertson
Journal:  Health Econ       Date:  2003-05       Impact factor: 3.046

3.  Helping poorer countries make locally informed health decisions.

Authors:  Kalipso Chalkidou; Ruth Levine; Andrew Dillon
Journal:  BMJ       Date:  2010-07-16

Review 4.  Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England.

Authors:  Michael Kelly; Antony Morgan; Simon Ellis; Tricia Younger; Jane Huntley; Catherine Swann
Journal:  Soc Sci Med       Date:  2010-07-14       Impact factor: 4.634

5.  Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.

Authors:  Bong-Min Yang; Kenneth Lee
Journal:  Value Health       Date:  2009 Nov-Dec       Impact factor: 5.725

6.  Is there a role for pharmacoeconomics in developing countries?

Authors:  Asrul Akmal Shafie; Mohamed Azmi Hassali
Journal:  Pharmacoeconomics       Date:  2011-01       Impact factor: 4.981

Review 7.  Economic evaluation in the US: what is the missing link?

Authors:  Peter J Neumann; Sean D Sullivan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 8.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 9.  Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.

Authors:  M Drummond
Journal:  Soc Sci Med       Date:  1994-06       Impact factor: 4.634

10.  Why prioritize when there isn't enough money?

Authors:  Daniel Wikler
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.